Maze Therapeutics Patents – Insights & Stats (Updated 2023)

Maze Therapeutics has a total of 21 patents globally, out of which no patents have been granted. Of these 21 patents, more than 95% patents are active. Canada is where Maze Therapeutics has filed the maximum number of patents, followed by Australia and United States of America. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Maze Therapeutics.

Maze Therapeutics was founded in the year 2018. The Company is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.

Do read about some of the most popular patents of Maze Therapeutics which have been covered by us in this article and also you can find Maze Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Maze Therapeutics patent portfolio.

How many patents does the founder and the CEO of Maze Therapeutics have?

The founder Charles Homcy has 6 patents and CEO Jason Coloma has 0 patent.

How many patents does Maze Therapeutics have?

Maze Therapeutics has a total of 21 patents globally. These patents belong to 5 unique patent families. Out of 21 patents, 20 patents are active.

How Many Patents did Maze Therapeutics File Every Year?

Maze Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantMaze Therapeutics Applications FiledMaze Therapeutics Patents Granted
20233
202210
20218

How many Maze Therapeutics patents are Alive/Dead?

Maze Therapeutics Patent Portfolio

 How Many Patents did Maze Therapeutics File in Different Countries?

Maze Therapeutics Worldwide Patent Filing

Countries in which Maze Therapeutics Filed Patents

CountryPatents
Canada4
Australia2
United States Of America2
Singapore1
Europe1
Taiwan1
Hong Kong (S.A.R.)1
Korea (South)1
Israel1
Japan1

Where are Research Centres of Maze Therapeutics Patents Located?

The Research Centre for all the Maze Therapeutics patents is the United States of America.

List of Maze Therapeutics Patents

Maze Therapeutics PatentsTitle
US20230265096A1Apol1 Inhibitors And Methods Of Use
US20230104740A1Inhibitors Of Glycogen Synthase 1 (Gys1) And Methods Of Use Thereof
EP4100527A2Compositions And Methods For Treating Neurodegenerative Diseases
WO2023141432A2Apol1 Inhibitors And Methods Of Use
WO2022216759A1Compositions And Methods For Treating Tdp-43 Proteinopathy
WO2022198196A1Inhibitors Of Glycogen Synthase 1 (Gys1) And Methods Of Use Thereof
WO2022178315A1Apol1 Inhibitors And Methods Of Use
WO2022170146A1Vectors Comprising Stuffer Polynucleotide Sequences
CA3179181A1Inhibitors Of Glycogen Synthase 1 (Gys1) And Methods Of Use Thereof
CA3179178A1Apol1 Inhibitors And Methods Of Use
CA3206272A1Vectors Comprising Stuffer Polynucleotide Sequences
CA3166978A1Compositions And Methods For Treating Neurodegenerative Diseases
AU2022218196A1Vectors Comprising Stuffer Polynucleotide Sequences
AU2021215934A1Compositions And Methods For Treating Neurodegenerative Diseases
HK40084683ACompositions And Methods For Treating Neurodegenerative Diseases
IL295284ACompositions And Methods For Treating Neurodegenerative Diseases
JP2023512836ACompositions And Methods For Treating Neurodegenerative Diseases
KR1020220139344ACompositions And Methods For Treating Neurological Diseases
SG11202251849QACompositions And Methods For Treating Neurodegenerative Diseases
TW202302570AInhibitors Of Glycogen Synthase 1 (Gys1) And Methods Of Use Thereof
WO2021159008A3Compositions And Methods For Treating Neurodegenerative Diseases

What are Maze Therapeutics key innovation segments?

What Technologies are Covered by Maze Therapeutics?

The chart below distributes patents filed by Maze Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Maze Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Maze Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Maze Therapeutics?

Table of Content

Insights you may find interesting

Related Articles

Driveu Patents – Insights & Stats (Updated 2024)

Driveu has a total of 12 patents globally, out of which 8 have been granted. Of these 12 patents, more than 91% patents are active. Israel is where Driveu has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, United States of America

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.